Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Centricity Cardio Enterprise[1] is an integrated Cardiovascular PACS (CVPACS) and Information System (CVIS) that bridges the gaps between care areas and healthcare information systems. You get a single point of access for patient data, wave forms, images, analysis tools and physician reports – combined with powerful end-to-end management, analytics and workflow tools across the cardiovascular care pathway.

Webinar | Coronavirus (COVID-19)

WEBINAR: Key Cardiovascular Metrics to Optimize Financial and Operational Outcomes

The financial burden of COVID-19 has put tremendous pressure on health systems across the country. This webinar will ...

June 10, 2020

A PCR genetic test nasal swab being taken from a patient to test if they are infected with COVID-19. While used as the primary test to diagnose coronavirus, up to 20 percent of patients will test negative even eight days after infection. Getty Images

News | Coronavirus (COVID-19)

COVID-19 Genetic PCR Tests Give False Negative Results if Used Too Early

June 10, 2020 — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 (COVID-19) too early ...

June 10, 2020

SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company of India focused on cardiology, announced it Hydra transcatheter aortic valve replacement (TAVR) device received European CE mark approval. It is indicated for the treatment of patients diagnosed with aortic stenosis. #SMT #HYDRA #TAVR

Feature | Heart Valve Technology

SMT Hydra TAVR System Receives European CE Mark Approval

June 9, 2020 — SMT (Sahajanand Medical Technology Private Ltd.), a leading medical device company in India focused on ...

June 09, 2020

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.

Feature | CT Angiography (CTA) | Dave Fornell, Editor

New Technologies Take Cardiac CT to the Next Level

Here is an overview of a few of the biggest technology advances in cardiovascular computed tomography (CT). These are ...

June 08, 2020

News | Heart Valve Technology

Edwards Sapien 3 Transcatheter Heart Valve Receives Approval In China

June 8, 2020 — Edwards Lifesciences Corp. announced Chinese regulatory approval for the Edwards Sapien 3 transcatheter ...

June 08, 2020

BD (Becton, Dickinson and Company, and Bard) launched the Halo One Thin-Walled Guiding Sheath, designed to perform as both a guiding sheath and an introducer sheath, for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.

News | Vascular Access

BD Launches of Halo One Thin-Walled Guiding Sheath

June 8, 2020 – BD (Becton, Dickinson and Company) launched the Halo One Thin-Walled Guiding Sheath, designed to perform ...

June 08, 2020

Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

The Cardiovascular Impact of COVID-19

It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger ...

June 05, 2020

Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational device exemption (IDE) application to start an early feasibility study with a first-in-human trial of the 9 French (Fr) Impella ECP heart pump. Impella ECP, which stands for "expandable cardiac power," will be studied in high-risk percutaneous coronary intervention (PCI) patients.

News | Hemodynamic Support Devices

FDA Approves First-in-Human Trial of Impella ECP World’s Smallest Heart Pump

June 5, 2020 — Abiomed announced the U.S. Food and Drug Administration (FDA) has approved the company's investigational ...

June 05, 2020

Videos | Hemodynamic Support Devices

VIDEO: Demonstration of Abiomed Impella ECP 9 French Transcatheter Ventricular Assist Device

This is a quick animation demonstrating how the new 9 French Abiomed Impella ECP expands to approximately 18 French and ...

June 05, 2020

All coronavirus content continued as the most popular content in May 2020. Two of the major topics included an article on the new Kawasaki-like inflammatory disease that affects children with COVID-19 and articles and videos on the cardiovascular effects of hydroxychloroquine in treating or preventing COVID. #COVID19 #SARScov2

Feature | Dave Fornell, Editor

June 4, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magaz ...

June 04, 2020

Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2

Feature | Cardiovascular Business

Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

June 03, 2020

he U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiomed Impella RP catheter-based heart pump to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE). #COVID19 #SARScov2

Feature | Coronavirus (COVID-19)

Impella RP Granted FDA Emergency Use Authorization for COVID-19 Patients With Right Heart Failure

June 1, 2020 — The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Abiom ...

June 01, 2020

Feature | Coronavirus (COVID-19)

New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19

May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still ...

May 29, 2020

Videos | Coronavirus (COVID-19)

VIDEO: Creating a Home COVID-19 Decontamination Area for the Clinician

Jay Mohan, D.O., RPVI, interventional cardiology fellow at William Beaumont Hospital, Royal Oak, Michigan, created this ...

May 29, 2020

News | Structural Heart

Neovasc Files CE Mark for Tiara TA Transapical Mitral Valve Replacement System

May 29, 2020 — Neovasc Inc., developer of a minimally invasive transcatheter mitral valve replacement (TMVR) ...

May 29, 2020